Literature DB >> 8887643

TC21 causes transformation by Raf-independent signaling pathways.

S M Graham1, A B Vojtek, S Y Huff, A D Cox, G J Clark, J A Cooper, C J Der.   

Abstract

Although the Ras-related protein TC21/R-Ras2 has only 55% amino acid identity with Ras proteins, mutated forms of TC21 exhibit the same potent transforming activity as constitutively activated forms of Ras. Therefore, like Ras, TC21 may activate signaling pathways that control normal cell growth and differentiation. To address this possibility, we determined if regulators and effectors of Ras are also important for controlling TC21 activity. First, we determined that Ras guanine nucleotide exchange factors (SOS1 and RasGRF/CDC25) synergistically enhanced wild-type TC21 activity in vivo and that Ras GTPase-activating proteins (GAPs; p120-GAP and NF1-GAP) stimulated wild-type TC21 GTP hydrolysis in vitro. Thus, extracellular signals that activate Ras via SOS1 activation may cause coordinate activation of Ras and TC21. Second, we determined if Raf kinases were effectors for TC21 transformation. Unexpectedly, yeast two-hybrid binding analyses showed that although both Ras and TC21 could interact with the isolated Ras-binding domain of Raf-1, only Ras interacted with full-length Raf-1, A-Raf, or B-Raf. Consistent with this observation, we found that Ras- but not TC21-transformed NIH 3T3 cells possessed constitutively elevated Raf-1 and B-Raf kinase activity. Thus, Raf kinases are effectors for Ras, but not TC21, signaling and transformation. We conclude that common upstream signals cause activation of Ras and TC21, but activated TC21 controls cell growth via distinct Raf-independent downstream signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887643      PMCID: PMC231616          DOI: 10.1128/MCB.16.11.6132

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Critical role of Rho in cell transformation by oncogenic Ras.

Authors:  G C Prendergast; R Khosravi-Far; P A Solski; H Kurzawa; P F Lebowitz; C J Der
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

2.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

3.  Biological assays for Ras transformation.

Authors:  G J Clark; A D Cox; S M Graham; C J Der
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Ras-mediated transcription activation: analysis by transient cotransfection assays.

Authors:  C A Hauser; J K Westwick; L A Quilliam
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 5.  Pathways of Ras function: connections to the actin cytoskeleton.

Authors:  G C Prendergast; J B Gibbs
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

6.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

9.  R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.

Authors:  A D Cox; T R Brtva; D G Lowe; C J Der
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

10.  A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1.

Authors:  L Han; J Colicelli
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more
  16 in total

1.  Rem2, a new member of the Rem/Rad/Gem/Kir family of Ras-related GTPases.

Authors:  B S Finlin; H Shao; K Kadono-Okuda; N Guo; D A Andres
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.

Authors:  M Rosário; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

Review 3.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.

Authors:  Tetsuya Niihori; Koki Nagai; Atsushi Fujita; Hirofumi Ohashi; Nobuhiko Okamoto; Satoshi Okada; Atsuko Harada; Hirotaka Kihara; Thomas Arbogast; Ryo Funayama; Matsuyuki Shirota; Keiko Nakayama; Taiki Abe; Shin-Ichi Inoue; I-Chun Tsai; Naomichi Matsumoto; Erica E Davis; Nicholas Katsanis; Yoko Aoki
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

5.  Essential function for the GTPase TC21 in homeostatic antigen receptor signaling.

Authors:  Pilar Delgado; Beatriz Cubelos; Enrique Calleja; Nuria Martínez-Martín; Angel Ciprés; Isabel Mérida; Carmen Bellas; Xosé R Bustelo; Balbino Alarcón
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

Review 6.  Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.

Authors:  James V Michael; Lawrence E Goldfinger
Journal:  Semin Cancer Biol       Date:  2017-12-02       Impact factor: 15.707

7.  Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.

Authors:  A McFall; A Ulkü; Q T Lambert; A Kusa; K Rogers-Graham; C J Der
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1.

Authors:  David Plows; Paraskevi Briassouli; Carolyn Owen; Vassilis Zoumpourlis; Michelle D Garrett; Alexander Pintzas
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

9.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.

Authors:  A W Lin; M Barradas; J C Stone; L van Aelst; M Serrano; S W Lowe
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

10.  Regulation of RasGRP via a phorbol ester-responsive C1 domain.

Authors:  C E Tognon; H E Kirk; L A Passmore; I P Whitehead; C J Der; R J Kay
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.